title: HPTN 052 and the future of HIV treatment and prevention.
authors.forename: Andy
authors.initials: A
authors.lastname: Seale
authors.forename: Jeffrey V
authors.initials: JV
authors.lastname: Lazarus
authors.forename: Ian
authors.initials: I
authors.lastname: Grubb
authors.forename: Ade
authors.initials: A
authors.lastname: Fakoya
authors.forename: Rifat
authors.initials: R
authors.lastname: Atun
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000191:economics; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D018023:HIV Seronegativity; D006679:HIV Seropositivity; D006801:Humans; D011322:Primary Prevention / Q000379:methods / Q000639:trends*; D016730:Program Development; D011634:Public Health / Q000639:trends; D016032:Randomized Controlled Trials as Topic; D040242:Risk Reduction Behavior; D012309:Risk-Taking; D012725:Sexual Behavior; D012747:Sexual Partners
chemical_list: D019380:Anti-HIV Agents